Oncology Institute posts 87% loss reduction on value-based care pivot, network expansion

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 14, 2025 · ~1 min read

Key Changes

• high

  Net loss improved 87% to $2.5M from $19.6M year-over-year, driven by 41% revenue growth, operating leverage (SG&A down to 19% of revenue from 24%), and $8.3M favorable swing in derivative liabilities.

  MD&A: Financial Results verify on EDGAR →
• high

  Capitated revenue surged 54% while fee-for-service revenue declined 10%, reflecting strategic shift to value-based contracts. Company now manages 2.0M patients under value-based agreements across expanded network.

  MD&A: Patient Services Revenue verify on EDGAR →
• high

  Clinic footprint nearly doubled to 155 from 81 through network provider model (275 Florida providers, 11 California providers added), while owned clinics declined slightly from 67 to 65—asset-light expansion strategy.

  MD&A: Business Overview verify on EDGAR →